Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Jade Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- −6 vs. Q1 2023
- Shares held
- 28.5M
- +2.49M (+9.6%) vs. Q1 2023
- Total value
- $488.3M
- −$35.8M (−6.8%) vs. Q1 2023
- New holders
- 3
- 24 more added
- Sold out
- 9
- 13 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 7 | $120 | 0.00% | +3+75.0% | Added |
| Metropolitan Life Insurance Co | 701 | $12.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 772 | $13.2K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 880 | $15.0K | 0.00% | +365+70.9% | Added |
| Tower Research Capital LLC (TRC) | 908 | $15.6K | 0.00% | −1,794−66.4% | Reduced |
| Russell Investments Group, Ltd. | 939 | $16.1K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,535 | $26.0K | 0.00% | +548+55.5% | Added |
| STRS Ohio | 2,300 | $39.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,999 | $51.4K | 0.00% | −2,987−49.9% | Reduced |
| Citigroup Inc | 3,324 | $57.0K | 0.00% | +3,095+1,351.5% | Added |
| Barclays PLC | 3,406 | $58.4K | 0.00% | −1,314−27.8% | Reduced |
| Wells Fargo & Company | 4,200 | $72.0K | 0.00% | +2,564+156.7% | Added |
| New York State Common Retirement Fund | 4,273 | $73.3K | 0.00% | −3,411−44.4% | Reduced |
| American International Group, Inc. | 4,844 | $83.1K | 0.00% | +412+9.3% | Added |
| Deutsche Bank AG | 4,985 | $85.5K | 0.00% | −654−11.6% | Reduced |
| MetLife Investment Management | 5,228 | $89.7K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 5,774 | $99.0K | 0.00% | +2,343+68.3% | Added |
| Bank of America Corp | 6,296 | $108.0K | 0.00% | −7,006−52.7% | Reduced |
| JPMorgan Chase & Co | 8,070 | $138.4K | 0.00% | +986+13.9% | Added |
| California State Teachers Retirement System | 9,896 | $169.7K | 0.00% | −1,063−9.7% | Reduced |
| Golden State Equity Partners | 10,530 | $180.6K | 0.05% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 11,720 | $201.0K | 0.00% | +11,720 | New |
| Rhumbline Advisers | 12,986 | $222.7K | 0.00% | −1,812−12.2% | Reduced |
| Ensign Peak Advisors, Inc | 15,000 | $257.3K | 0.00% | 00.0% | Unchanged |
| Swiss National Bank | 16,201 | $277.8K | 0.00% | −2,400−12.9% | Reduced |
| Alps Advisors Inc | 18,320 | $314.2K | 0.00% | +2,112+13.0% | Added |
| Parkwood LLC | 22,832 | $392.0K | 0.07% | −3,031−11.7% | Reduced |
| Dimensional Fund Advisors LP | 25,011 | $428.4K | 0.00% | +13,397+115.4% | Added |
| Charles Schwab Investment Management Inc | 26,673 | $457.4K | 0.00% | +2,032+8.2% | Added |
| Bank of New York Mellon Corp | 27,232 | $467.0K | 0.00% | −563−2.0% | Reduced |
| Two Sigma Investments, LP | 30,011 | $514.7K | 0.00% | +18,502+160.8% | Added |
| Morgan Stanley | 33,026 | $566.4K | 0.00% | −11,948−26.6% | Reduced |
| Millennium Management LLC | 33,387 | $572.6K | 0.00% | +12,595+60.6% | Added |
| Nuveen Asset Management, LLC | 36,310 | $622.7K | 0.00% | 00.0% | Unchanged |
| HighVista Strategies LLC | 41,803 | $716.9K | 0.33% | +25,970+164.0% | Added |
| Nan Fung Group Holdings Ltd | 47,936 | $822.1K | 0.53% | 00.0% | Unchanged |
| Eversept Partners, LP | 50,242 | $861.6K | 0.09% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $872.0K | 0.01% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 57,874 | $992.5K | 0.01% | −46,174−44.4% | Reduced |
| Northern Trust Corp | 87,997 | $1.51M | 0.00% | +10,558+13.6% | Added |
| Nantahala Capital Management, LLC | 95,000 | $1.63M | 0.20% | 00.0% | Unchanged |
| State Street Corp | 188,874 | $3.24M | 0.00% | +4,281+2.3% | Added |
| Ghost Tree Capital, LLC | 201,197 | $3.45M | 1.25% | +1,197+0.6% | Added |
| Geode Capital Management, LLC | 203,058 | $3.48M | 0.00% | +15,559+8.3% | Added |
| Citadel Advisors LLC | 291,938 | $5.01M | 0.01% | +291,938 | New |
| Vanguard Group Inc | 523,567 | $8.98M | 0.00% | +10,255+2.0% | Added |
| OUP Management Co., LLC | 603,762 | $10.4M | 17.66% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 621,712 | $10.7M | 1.49% | 00.0% | Unchanged |
| BlackRock Inc. | 622,647 | $10.7M | 0.00% | +22,648+3.8% | Added |
| FMR LLC | 727,614 | $12.5M | 0.00% | +156,649+27.4% | Added |
| OrbiMed Advisors LLC | 756,930 | $13.0M | 0.25% | 00.0% | Unchanged |
| Great Point Partners LLC | 932,158 | $16.0M | 3.20% | +176,538+23.4% | Added |
| Frazier Life Sciences Management, L.P. | 994,858 | $17.1M | 1.02% | +656,748+194.2% | Added |
| Driehaus Capital Management LLC | 1,194,091 | $20.5M | 0.26% | +1,194,091 | New |
| Cormorant Asset Management, LP | 1,561,696 | $26.8M | 1.53% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,963,479 | $33.7M | 0.19% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $35.0M | 4.35% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $37.8M | 6.19% | +1,120,000+103.6% | Added |
| Sofinnova Investments, Inc. | 3,758,686 | $64.5M | 4.26% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $141.7M | 2.68% | 00.0% | Unchanged |
| VR Adviser, LLC | 0 | $0 | 0.00% | −833,927−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −195,146−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −69,119−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −39,573−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −15,958−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | 0 | $0 | 0.00% | −13,190−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |